Functional Recovery After Chemotherapy- and Radiotherapy-Induced Gastrointestinal Injury: Mechanisms, Clinical
Kun Ju1, Yuanli Shan2, Limin Pan3
1Office of Drug Clinical Trials, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150001, People's Republic of China.
Cancer treatments like chemotherapy and radiotherapy can cause lasting gastrointestinal problems. A new recovery-focused framework helps assess and manage bowel dysfunction for better patient outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Regenerative Medicine
Background:
- Gastrointestinal injury from chemotherapy and radiotherapy is a frequent complication of cancer treatment.
- This injury can lead to acute symptoms and persistent bowel dysfunction, impacting patient quality of life.
- Current terminology like 'toxicity' or 'mucositis' inadequately describes incomplete functional recovery.
Purpose of the Study:
- To propose a practical, recovery-oriented framework for assessing and managing gastrointestinal injury after cancer treatment.
- To define meaningful recovery across structural, barrier, clinical, and patient-centered domains.
- To guide improved clinical decision-making and patient care.
Main Methods:
- Summarizing the acute-to-chronic spectrum of gastrointestinal injury.
- Examining mechanisms underlying failed recovery.
- Reviewing current clinical assessment and management strategies.
- Discussing emerging therapeutic approaches.
Main Results:
- A proposed four-domain recovery-oriented framework (structural, barrier, clinical, patient-centered).
- Identification of mechanisms contributing to persistent bowel dysfunction.
- Overview of current supportive and emerging regenerative strategies.
- Highlighting the need to integrate multiple data points for recovery assessment.
Conclusions:
- A recovery-oriented model offers a more comprehensive approach than symptom-centered care.
- Integrating symptom trajectory, nutritional status, and patient-reported outcomes is crucial.
- Emerging strategies like biomarker monitoring and microbiome interventions show promise.
- This framework can improve monitoring and restoration of gastrointestinal function post-cancer treatment.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...

